115 related articles for article (PubMed ID: 20336920)
1. ProEx C stain analysis in recurrent respiratory papillomatosis.
Bhandarkar ND; Sims HS; David O
Ann Otol Rhinol Laryngol; 2010 Feb; 119(2):99-104. PubMed ID: 20336920
[TBL] [Abstract][Full Text] [Related]
2. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
Badr RE; Walts AE; Chung F; Bose S
Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
[TBL] [Abstract][Full Text] [Related]
3. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.
Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK
Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
[TBL] [Abstract][Full Text] [Related]
5. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.
Boucher J; Anku-Bertholet C; Temmar R; Pelmus M
Hum Pathol; 2009 Jun; 40(6):904-5; author reply 905-6. PubMed ID: 19442790
[No Abstract] [Full Text] [Related]
7. Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.
Siddiqui MT; Cohen C; Nassar A
Am J Clin Pathol; 2008 Nov; 130(5):765-70. PubMed ID: 18854269
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions.
Shi J; Liu H; Wilkerson M; Huang Y; Meschter S; Dupree W; Schuerch C; Lin F
Hum Pathol; 2007 Sep; 38(9):1335-44. PubMed ID: 17512033
[TBL] [Abstract][Full Text] [Related]
9. Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology.
Beccati MD; Buriani C; Pedriali M; Rossi S; Nenci I
Cancer; 2008 Jun; 114(3):196-203. PubMed ID: 18442059
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase alpha II, retinoblastoma gene product, and p53: potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis.
Gupta D; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):86-91. PubMed ID: 11277421
[TBL] [Abstract][Full Text] [Related]
11. BD ProEx C immunostaining in extramammary Paget's disease and perineal melanoma.
Walts AE; Bose S
Mod Pathol; 2009 Feb; 22(2):246-51. PubMed ID: 18931649
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
[TBL] [Abstract][Full Text] [Related]
13. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.
Shroyer KR; Homer P; Heinz D; Singh M
Cancer; 2006 Oct; 108(5):324-30. PubMed ID: 16937378
[TBL] [Abstract][Full Text] [Related]
14. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
[TBL] [Abstract][Full Text] [Related]
15. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
[TBL] [Abstract][Full Text] [Related]
16. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
[TBL] [Abstract][Full Text] [Related]
17. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
Aximu D; Azad A; Ni R; Colgan T; Nanji S
Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.
Yan S; Coffing BN; Li Z; Xie H; Brennick JB; Beg HA; Froehlich HM; Wells WA
Anticancer Res; 2016 Jun; 36(6):2871-80. PubMed ID: 27272799
[TBL] [Abstract][Full Text] [Related]
19. Expression of ProEx C in primary and metastatic urothelial carcinoma.
Liu L; Cohen C; Siddiqui MT
Diagn Cytopathol; 2015 Mar; 43(3):181-7. PubMed ID: 24975746
[TBL] [Abstract][Full Text] [Related]
20. Dysplasia in adults with recurrent respiratory papillomatosis: incidence and risk factors.
Blumin JH; Handler EB; Simpson CB; Osipov V; Merati AL
Ann Otol Rhinol Laryngol; 2009 Jul; 118(7):481-5. PubMed ID: 19708485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
